Company Insider Tape

Cue Biopharma insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol CUE Latest filing 13 Jul 2026

Company Read

Acquisition-led

CUE has 15 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%. The largest stored filing is $1000.0K from LIN, SHAO-LEE.

Latest filing 13 Jul 2026most recent stored row
Largest filing $1000.0Kreported transaction value
Total filings 15stored transaction rows
Acquisition value $1000.0K15 acquisitions
Disposal value $00 disposals
Net value $1000.0Kacquisitions minus disposals

Filing cadence

Last 12 active months
May 2026 4
Jun 2026 2
Jul 2026 9

Acquisitions 100.0% · Disposals 0.0%

May 2026 $0
Jun 2026 $1000.0K
Jul 2026 $0

Executive concentration

By filing count
LIN, SHAO-LEE Director, Chief Executive Officer · 3 filings
CAMARDO, DANIEL A. Director · 2 filings
LIN, SHAO-LEE Director, CHIEF EXECUTIVE OFFICER · 2 filings
BORIE, DOMINIQUE CHRISTIAN Chief Medical Officer, Head of Research & Development · 2 filings
MEEHAN, VIOLA MONG Director · 2 filings
SARRAF, PASHA Director · 1 filings
MELUZIO, MICHAEL VINCENT VP, Prin. Accounting Officer · 1 filings
RAY, SUMITA Chief Legal Compliance Officer, Corporate Secretary · 1 filings

Market Context

CUE weekly market snapshot

Week 31 Jul 2026
Latest close 26.84 USDstored weekly close
1-week move -16.4%latest weekly bar
13-week move -5.0%medium-term context
Relative Strength 29.9Sharemaestro indicator
Fair value gap -27.1%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for CUE

Showing 1-15 of 15
Date 13 Jul 2026
Insider BORIE, DOMINIQUE CHRISTIANChief Medical Officer, Head of Research & Development
Side Acquisition
Shares 31500
Price 0.00
Value 0
Security Common Stock
Date 13 Jul 2026
Insider BORIE, DOMINIQUE CHRISTIANChief Medical Officer, Head of Research & Development
Side Acquisition
Shares 63000
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 9 Jul 2026
Insider CAMARDO, DANIEL A.Director
Side Acquisition
Shares 21800
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider GARZONE, PAMELADirector
Side Acquisition
Shares 21800
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider LIN, SHAO-LEEDirector, Chief Executive Officer
Side Acquisition
Shares 327537
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider MEEHAN, VIOLA MONGDirector
Side Acquisition
Shares 21800
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider MELUZIO, MICHAEL VINCENTVP, Prin. Accounting Officer
Side Acquisition
Shares 40942
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider RAY, SUMITAChief Legal Compliance Officer, Corporate Secretary
Side Acquisition
Shares 54589
Price 0.00
Value 0
Security Common Stock
Date 9 Jul 2026
Insider SARRAF, PASHADirector
Side Acquisition
Shares 21800
Price 0.00
Value 0
Security Common Stock
Date 1 Jun 2026
Insider LIN, SHAO-LEEDirector, Chief Executive Officer
Side Acquisition
Shares 45453
Price -
Value -
Security Common Stock Warrants (Right to Buy)
Date 1 Jun 2026
Insider LIN, SHAO-LEEDirector, Chief Executive Officer
Side Acquisition
Shares 90906
Price 11.00
Value 999966
Security Pre-Funded Warrants (Right to Buy)
Date 30 May 2026
Insider CAMARDO, DANIEL A.Director
Side Acquisition
Shares 1626
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 30 May 2026
Insider MEEHAN, VIOLA MONGDirector
Side Acquisition
Shares 1626
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 3 May 2026
Insider LIN, SHAO-LEEDirector, CHIEF EXECUTIVE OFFICER
Side Acquisition
Shares 655074
Price 0.00
Value 0
Security Stock Option (right to buy)
Date 3 May 2026
Insider LIN, SHAO-LEEDirector, CHIEF EXECUTIVE OFFICER
Side Acquisition
Shares 327537
Price 0.00
Value 0
Security Common Stock